SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " drug " 1,589 found 🔀 AI-powered Shuffle
Healthy Returns: Botox, Trulicity among 15 drugs added to Medicare price negotiations
The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay a historic settlement.
Scientists turn tumor immune cells into cancer killers
Scientists at KAIST have found a way to turn a tumor’s own immune cells into powerful cancer fighters—right inside the body. Tumors are packed with macrophages, immune cells that should attack cancer but are usually silenced by the tumor environment. By injecting a specially designed drug directly into tumors, researchers were able to “reprogram” these dormant cells to recognize and destroy cancer.
Congress is poised to take this big step intended to lower drug costs
A deal attached to the Senate government funding package would "delink" PBM compensation from drug prices in Medicare Part D.
Nevada ranks near the bottom for health. Here’s why
Nevada ranks among the least healthy states, driven by poor outcomes in housing, non-medical drug use and access to care.
This discovery could let bones benefit from exercise without moving
Researchers have discovered a biological switch that explains why movement keeps bones strong. The protein senses physical activity and pushes bone marrow stem cells to build bone instead of storing fat, slowing age-related bone loss. By targeting this “exercise sensor,” scientists believe they could create drugs that mimic exercise at the molecular level. The approach could protect fragile bones in people who are unable to stay active.
Industry Leaders Predict Life Science Trends for 2026
2026 will be the year that artificial intelligence accelerates multiple aspects of the drug discovery and development pipeline, industry leaders predict.
Marseille’s drug war reshapes France’s political battlefield
A surge in violence is dominating the mayoral contest as French politics gears up for next year’s presidential election.
Army vet wins $6.8 million from jury after suing LAPD over mental health '5150' hold
Slade Douglas filed a lawsuit against the LAPD and City of Los Angeles over an August 2019 incident in which he says he was forcibly hospitalized and drugged after officers responded to a report that he might be suicidal.
Alzheimer’s may trick the brain into erasing its own memories
Alzheimer’s may destroy memory by flipping a single molecular switch that tells neurons to prune their own connections. Researchers found that both amyloid beta and inflammation converge on the same receptor, triggering synapse loss. Surprisingly, neurons aren’t passive victims—they actively respond to these signals. Targeting this receptor could offer a new way to protect memory beyond current amyloid-focused drugs.
Powdered Whole Milk Could Be a Culprit in the ByHeart Botulism Outbreak, Tests Show
Powdered whole milk used to make ByHeart infant formula could be a source of contamination that led to an outbreak of botulism that has sickened dozens of babies, U.S. health officials indicated Friday. Testing by the U.S. Food and Drug Administration found the type of bacteria that can cause the ...
Owner of La Popular money service business sentenced to over 3 years for laundering drug money
The owner of La Popular, a money-service business with multiple locations, including in Woodburn, Hillsboro and Beaverton, has been sentenced to prison for laundering drug trafficking funds. On Wednesday, Jan. […]
CVS Health (CVS) Valuation Check As Regulatory Scrutiny And Legal Outcomes Draw Investor Focus
Regulatory and legal scrutiny is back in focus for CVS Health (CVS), as a U.S. House Judiciary Committee probe into its pharmacy benefit manager practices unfolds, while a separate class action over prescription drug pricing has been dismissed. See our latest analysis for CVS Health. For context, CVS Health shares now trade at US$82.68, with a 30 day share price return of 5.95% and a year to date share price return of 3.18%, while the 1 year total shareholder return of 59.48% reflects how...
NextCure Provides Business Update
SIM0505 (CDH6 ADC) Phase 1 dose escalation data update anticipated in Q2 2026LNCB74 (B7-H4 ADC) Phase 1 dose escalation expanded into higher dose cohorts BELTSVILLE, Md., Jan. 23, 2026 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to developing novel therapies to treat cancer, today provided updates for its two antibody drug conjugate (ADC) programs and reported a preliminary year-end 2025 cash position. SIM0505 (CDH6 ADC): Phase 1 dose e
Monoclonal Antibodies in Veterinary Health Market Research 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031
The monoclonal antibodies in veterinary health market face growth opportunities due to rising animal chronic diseases and pet humanization trends. Advanced, safer biologic therapies are favored over traditional drugs, supported by increased pet insurance. However, high costs present a major market entry barrier. Monoclonal Antibodies in Veterinary Health Market Monoclonal Antibodies in Veterinary Health Market Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "Monoclonal Antibodies in Veterinary Hea
I’m a doctor who knows better — but I switched to an inferior drug to save money
Cost-sharing insurance plans were supposed to decrease overall spending. Instead, patients — not payers — shoulder the burden of their medical costs.
Big Insurers Try to Shift Blame for High Health Costs to Hospitals and Drug Makers
At two congressional hearings, lawmakers slammed executives of major companies, saying they were failing to rein in the cost of medical care for consumers.
Can leucovorin treat autism? History says, probably not
Parents of autistic children are clamoring for a prescription vitamin promoted by federal health officials. But there's little evidence the drug will help.
Oregon business owner gets prison for laundering drug money to Mexico
Mother of three children, all U.S. citizens, now faces deportation after using her La Popular stores to transfer millions in drug proceeds.
Congress’ health deal still has hurdles
The package, which would put guardrails on to drug intermediaries, faces a tough test this week.
Insurers point to providers, drugmakers for driving up health costs
Health insurance CEOs plan to blame hospitals and drugmakers when they testify to Congress on affordability Thursday.
Merck partners with global health coalition to develop affordable Ebola vaccine
Merck and the Coalition for Epidemic Preparedness Innovations said on Wednesday they have partnered on a $30 million program to develop an updated version of the drugmaker's Ebola vaccine aimed at improving affordability and access for low- and middle-income countries.
‘Remote controlled’ proteins illuminate living cells
Nature - The discovery that some fluorescent proteins are sensitive to magnets could lead to the development of switchable drugs and biosensors.
Tiny doses of THC show big benefits for HIV treatment
A new study suggests that micro-doses of THC could help counter many long-term side effects of HIV treatment without causing intoxication. In animal models, low-dose THC reduced inflammation, improved gut bacteria, boosted serotonin, and lowered harmful cholesterol and bile acids. Surprisingly, it also reduced circulating levels of antiretroviral drugs while maintaining viral suppression, potentially protecting the liver. Scientists say the results point to a promising new approach for managing chronic complications of HIV.
Medicaid has a new way to pay for costly sickle cell treatment: Only if it works
Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model for all gene therapies being developed.
Congress revives bipartisan health care proposal, including drug middlemen provisions
Elements of a health care deal that was blown up by Elon Musk are getting a fresh look in Congress.
A common painkiller may be quietly changing cancer risk
Ibuprofen may be doing more than easing aches and pains—it could also help reduce the risk of some cancers. Studies have linked regular use to lower rates of endometrial and bowel cancer, likely because the drug dampens inflammation that fuels tumor growth. Researchers have even found it can interfere with genes cancer cells rely on to survive. Still, experts warn that long-term use carries risks and shouldn’t replace proven prevention strategies.
Scientists discover why some wounds refuse to heal
Scientists have uncovered a surprising reason why some chronic wounds refuse to heal, even when treated with antibiotics. A common bacterium found in long-lasting wounds does not just resist drugs. It actively releases damaging molecules that overwhelm skin cells and stop them from repairing tissue. Researchers discovered that neutralizing these harmful molecules with antioxidants allows skin cells to recover and restart healing.
Marijuana's Restrictive Federal Classification Isn't Supported By Science, New Study Concludes
Marijuana and other drugs are not as dangerous as laws written half a century ago say they are, according to a new scientific review. Since the passage of the Controlled Substances Act (CSA) in 1970, U.S. drug laws have been dictated by rigid categories that supposedly reflect the dangers posed by different substances—but the new […]
I talked to many health CEOs out West and see big things for drug stocks
Health care is going to resume its rightful place in big-time managers' portfolios.
Viruses that evolved on the space station and were sent back to Earth were more effective at killing bacteria
Near-weightless conditions can mutate genes and alter the physical structures of bacteria and phages, disrupting their normal interactions in ways that could help us treat drug-resistant infections.
Scientists sent viruses to space and they evolved in surprising ways
When scientists sent bacteria-infecting viruses to the International Space Station, the microbes did not behave the same way they do on Earth. In microgravity, infections still occurred, but both viruses and bacteria evolved differently over time. Genetic changes emerged that altered how viruses attach to bacteria and how bacteria defend themselves. The findings could help improve phage therapies against drug-resistant infections.
Health experts warn about potentially deadly herbal substance, after 6 overdose deaths: What to know
The California Department of Public Health is sounding the alarm on Kratom, as well as a potent derivative of the plant called 7-OH, in the wake of six recent overdose deaths in Los Angeles County. Kratom and 7-OH products are not FDA-approved and are not legal for retailers to sell.
My research helped invent Ozempic — then male scientists took all the credit
The work of the biochemist Svetlana Mojsov was instrumental in the development of the diet drugs that are now slimming the world. She tells Aimee Donnellan about her 40-year fight for recognition
Trump administration quietly abandons plan to merge ATF and DEA after pressure from both sides of gun debate
After pushback from both gun rights and gun control groups, the Trump administration has quietly abandoned its plan to merge the Bureau of Alcohol, Tobacco, Firearms and Explosives into the Drug Enforcement Administration, according to people briefed on the matter.
What science says about how weight-loss drugs affect cancer risk
Evidence is mounting that GLP-1 drugs may play a role in reducing cancer risk and deaths from certain cancers.
JPM26: Chugai chases new science and name recognition from US biopharma industry
The leaders of Chugai Pharmaceutical are tired of their company not getting its due. At the J.P. | The leaders of Chugai Pharmaceutical are tired of their company not getting its due. At the J.P. Morgan Healthcare Conference in San Francisco, they’re working hard to change that while also seeking out new science to bring into their storied drug discovery operation.
UK health regulator approves up to 7.2 mg weekly dose of Wegovy for obesity patients
Britain's health regulator approved a maximum dose of up to 7.2 miligrams per week of Novo Nordisk's blockbuster weight-loss drug Wegovy for patients with obesity only, it said on Friday.
What's in the Trump health care plan? White House releases blueprint.
Trump called on Congress to pass a series of measures aimed at lowering drug prices and health insurance costs in his long-awaited health care plan.
Trump health care plan doesn't help people facing skyrocketing ACA premiums
President Trump announced a plan that addresses drug costs and health savings accounts, but not the health insurance premium spikes millions of Americans are facing.
Federal mental health and addiction funding for Oregonians fully restored, 24 hours after Trump cut it
The funding supports a wide variety of mental health and addiction initiatives, ranging from youth suicide prevention to drug and alcohol treatment programs.
Trump unveils health care affordability plan
President Trump unveiled a health care framework Thursday aimed at lowering drug prices and insurance premiums, as he seeks to address a major Republican political liability ahead of the midterm el…
Trump unveils health care plan aimed at lowering costs
President Donald Trump unveiled a multipart proposal on Thursday aimed at lowering prescription drug prices and reducing health insurance premiums, as well as increasing pricing transparency. He also vowed to hold big insurance companies accountable.
President Trump Unveils The Great Healthcare Plan to Lower Costs and Deliver Money Directly to the People
President Donald J. Trump’s Great Healthcare Plan is a broad healthcare initiative that will slash prescription drug prices, reduce insurance premiums,
Healey to eliminate insurer prior authorizations for some drugs and services
Prior authorizations have long been hated by many, but insurers call them an essential tool they use to control spending.
Trump administration sends letter wiping out addiction, mental health grants
The Trump administration sent hundreds of letters Tuesday terminating federal grants supporting mental health and drug addiction services.
Drug use disorders a growing public health concern in the Americas, PAHO study finds
Washington, D.C., 14 January 2026 (PAHO) – Drug use disorders are a major and growing public health problem in the Americas. Drug use is among the top 10 risk factors contributing to all-cause mortality and disability in the Region, according to findings published in the Pan American Journal of Public Health.In 2021, an estimated 17.7 million people in the Americas were living with a drug use disorder, resulting in nearly 78,000 deaths directly attributable to these disorders, representing a mortality rate four times higher than the global average.
Fact check: Trump’s Detroit economic speech
Inflation hasn’t “stopped.” Consumer prices are up during this presidential term, not “down.” Grocery prices are rising, not starting to fall “rapidly.” US businesses and consumers, not China, pay US tariffs on Chinese imports. It’s impossible to reduce prescription drug prices by “thousands” of percentage points, since this would mean Americans would be getting paid to acquire their medicines.
Daniel Perez warns of tough choices in 2026 as House braces for tax, insurance, drug-cost battles
‘But difficult doesn’t mean impossible, and hard isn’t an excuse for cowardice.’
National health ranking puts Georgia near bottom of list. Here's why
An annual health report from UnitedHealth report found Georgia ranked 38th nationally, in part from recreational drug use and high costs.
Pazdur warns that politics, ‘chaos’ are damaging FDA
At a STAT event, veteran drug regulator Richard Pazdur, who left the FDA last month after 26 years, said that politics and 'chaos' were damaging the agency.
Scientists Resurrected Extinct Cannabis Enzymes And Traced The Drug's Origins
Can't beat the classics.
Trump is pledging to ‘rescue’ protesters in Iran. He has a selective view of the sanctity of protests.
President Donald Trump billed strikes on Venezuela earlier this month as being about drugs, gangs invading the United States and law enforcement – i.e. arresting indicted leader Nicolás Maduro. But of late, he seems conspicuously preoccupied with the country’s oil wealth.
MBX Biosciences to Provide 2026 Outlook and Business Update at 44th Annual J.P. Morgan Healthcare Conference
One-year follow-up data from Phase 2 trial of once-weekly canvuparatide, a potential best-in-class therapy for hypoparathyroidism, anticipated in Q2 2026; Phase 3 initiation on track for Q3 2026 12-week data from Phase 1 trial of MBX 4291, a dual GLP-1/GIP co-agonist prodrug with potential for once-monthly dosing and improved tolerability for obesity, anticipated in Q4 2026 Nomination of two additional obesity candidates expected in 2026: an amycretin prodrug and a GLP-1/GIP/GCGR triple agonist,
Newly discovered coffee compounds beat diabetes drug in lab tests
Roasted coffee may do more than wake you up—it could help control blood sugar. Researchers discovered several new coffee compounds that inhibit α-glucosidase, a key enzyme linked to type 2 diabetes. Some of these molecules were even more potent than a common anti-diabetic drug. The study also introduced a faster, greener way to uncover health-boosting compounds in complex foods.
Healthy Returns: What to expect from pharma at the JPM conference
At the JPMorgan Healthcare Conference, drugmakers are expected to roll out key business and drug pipeline updates and splashy M&A deals.
Trump signals US to start striking drug cartels in Mexico
President Trump said the US will begin targeting drug cartels with military strikes, and suggested the operations could take place in Mexico.
The US attacked Venezuela. Does Trump want to attack Mexico next?
President Donald Trump addressed potential anti-drug strikes in Mexico in a Jan. 8 interview. Here's what to know.
The Weight-Loss Drug Revolution—From Shots to Pills and the Science behind It All
Behind the hype of GLP-1 medications lies complex science, serious side effects and a pharmaceutical arms race.
Less than two years after stopping obesity drugs, weight and health issues return, study finds
When patients stop taking weight-loss medications, the beneficial effects of the drugs on weight and other health issues disappear within two years, a large analysis of earlier research has found.
Stopping obesity drugs means people regain weight and lose heart health benefits
Why the weight, and heart risks, return after stopping GLP-1 drugs.
Another nexus of fraud? Auditor zeros in on drug, mental health grants
One unnamed grant manager with BHA approved a payment of $672,647 to a new vendor for a single month’s work, then left state employment a few days later. That grant manager subsequently provided consulting services to the provider.
US FDA to limit regulation of health and fitness wearables, commissioner says
The U.S. Food and Drug Administration said on Tuesday that it will limit regulation of wearable devices and software designed to support healthy lifestyles, issuing new guidance to clarify its regulatory approach.
Trump tells GOP it’s time to ‘own’ health care while urging ‘flexibility’ on abortion restrictions
The president argued that rising health care costs, particularly prescription drug prices, had given Republicans an opening to compete with Democrats on affordability.
US capture of Maduro divides Latin America, thrilling Trump's allies and threatening his foes
Through a combination of tariffs, sanctions and military force, he has pressured Latin American leaders to advance his administration's goals of combating drug trafficking, halting immigration, securing strategic natural resources and countering the influence of Russia and China.
Maduro says 'I was captured' as he pleads not guilty on drug trafficking charges
Maduro declared himself "innocent" and a "decent man"
Wegovy obesity pill now available at pharmacies
Drugmaker Novo Nordisk said the prescription medicine can be found at a range of pharmacies, including CVS and Costco, as well as some telehealth providers.
An AI revolution in drugmaking is under way
It will transform how medicines are made—and the industry itself
The science of losing weight : Life Kit: Health
When it comes to weight loss, there are many misconceptions about what works. So if you want to lose weight this year, here's what the science says about the potential health benefits, GLP-1 drugs, exercise and more.Sign up for Life Kit's Guide to Building Strength here: npr.org/strongerFollow us on Instagram: @nprlifekitSign up for our newsletter here.Have an episode idea or feedback you want to share? Email us at lifekit@npr.orgSupport the show and listen to it sponsor-free by signing up for Life Kit+ at plus.npr.org/lifekit
The science of losing weight : Life Kit: Health
When it comes to weight loss, there are many misconceptions about what works. So if you want to lose weight this year, here's what the science says about the potential health benefits, GLP-1 drugs, exercise and more.Sign up for Life Kit's Guide to Building Strength here: npr.org/strongerFollow us on Instagram: @nprlifekitSign up for our newsletter here.Have an episode idea or feedback you want to share? Email us at lifekit@npr.orgSupport the show and listen to it sponsor-free by signing up for Life Kit+ at plus.npr.org/lifekit
The science of losing weight : Life Kit
When it comes to weight loss, there are many misconceptions about what works. So if you want to lose weight this year, here's what the science says about the potential health benefits, GLP-1 drugs, exercise and more.Sign up for Life Kit's Guide to Building Strength here: npr.org/strongerFollow us on Instagram: @nprlifekitSign up for our newsletter here.Have an episode idea or feedback you want to share? Email us at lifekit@npr.orgSupport the show and listen to it sponsor-free by signing up for Life Kit+ at plus.npr.org/lifekit
Scientists uncover a hidden switch that helps cancer cells thrive
A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer metabolism by controlling the powerful mTOR growth pathway, tying survival and energy use together. This insight explains why MCL1-targeting drugs can be effective—but also why they sometimes damage the heart. Researchers have now identified a way to reduce that risk, potentially unlocking safer cancer therapies.
To Knock Down Health-System Hurdles Between You and HIV Prevention, Try These 6 Things
It’s been more than 10 years since the FDA first approved an HIV prevention drug. Today, people who could benefit from preexposure prophylaxis often struggle to access the lifesaving medicine or run into doctors without the education or empathy to offer affirming care. And those lapses can produce billing headaches.
One doctor's experience shows the battle for the future of addiction medicine
The experiences of one doctor in Louisiana reveal the tensions around trying to get people to engage in addiction treatment, even if they're not ready to stop using drugs.
Health Care Providers Are Dropping a Common Anesthesia Drug That’s Also a Climate Super Pollutant
Limiting use of desflurane helps hospitals reduce their greenhouse gas emissions; the European Union now prohibits its use during most procedures.
First US at-home depression kit on its way after trial shows benefits in weeks
In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved the first at-home brain-stimulation device to treat moderate to severe major depressive disorder (MDD).
Lenny Dykstra facing drug charges following traffic stop, police say
Coast Guard suspends search for people who abandoned ship after US strikes on alleged drug boats
The US Coast Guard announced Friday night it has suspended its search for people in the water after US strikes on alleged drug boats in the eastern Pacific Ocean earlier this week.
Think 2025 Was a Big Year for Health News? Fasten Your Seat Belts
Raging measles cases, questions about drug approvals and spiking insurance premiums lie ahead.
In one year, Trump pivots fentanyl response from public health to drug war
Experts say Biden's focus on addiction health care saved tens of thousands of lives and slowed fentanyl smuggling. Trump scrapped Biden's approach in favor of military strikes.
Colchester boy given £1.8m drug has new lease of life
Five-year-old Edward can walk independently, his mum says, and she hopes he will lead a happy life.
Cancer Capitalism: How Drug Companies and Health Providers Profit
Leading to overcharges, treatments that don’t extend lives and failed implants.
Three major health care policy issues to watch in 2026
ACA premium subsidies, drug pricing changes, and PBM reforms are among the issues to watch.
Novo Nordisk's 'long game' on weight loss drugs sparks hope in science, but the Street is impatient
The medicine developed by the100-year old Danish drugmaker may impact patients' brains in surprising ways
Why Americans are facing rising health insurance costs
Experts point to several factors behind the surge in health insurance prices, including general inflation, the growing use of high-cost prescription drugs, and consolidation among medical providers.
Kratom and 7-OH products are widely available. They’re also at the heart of a public health debate. : Short Wave
Kratom and 7-OH products are available in many smoke shops. But earlier this year, the FDA recommended certain 7-OH products be scheduled alongside opioids. This isn’t the first time kratom has come under scrutiny. Nearly a decade ago, the DEA wanted to make certain active ingredients in kratom controlled substances. Meaning products would go from being widely available to highly restricted. After a massive wave of protest, the DEA decided not to move forward. Producer Rachel Carlson joins host Emily Kwong to talk about what could happen this time around, and what scientists know – and don’t know – about kratom and 7-OH. Interested in more of the science behind drugs and supplements? Email us your question at shortwave@npr.org.Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.
ADHD drugs don’t work the way we thought
ADHD stimulants appear to work less by sharpening focus and more by waking up the brain. Brain scans revealed that these medications activate reward and alertness systems, helping children stay interested in tasks they would normally avoid. The drugs even reversed brain patterns linked to sleep deprivation. Researchers say this could complicate ADHD diagnoses if poor sleep is the real underlying problem.
Mini brains reveal clear brain signals of schizophrenia and bipolar disorder
Tiny lab-grown brains are offering an unprecedented look at how schizophrenia and bipolar disorder disrupt neural activity. Researchers found distinct electrical firing patterns that could identify these conditions with high accuracy. The discovery opens the door to more precise diagnoses and personalized drug testing. Instead of guessing medications, doctors may one day see what works before treating the patient.
ADHD drugs may work indirectly to boost attention
Drugs like Adderall and Ritalin appear to help children with ADHD by activating brain areas involved in alertness and motivation.
Weight loss drugs and AI in health care: a look at 2025's top health stories
Recapping the headlines that affected American's health in 2025
A surprising brain cleanup reduced epileptic seizures and restored memory
A new study suggests temporal lobe epilepsy may be linked to early aging of certain brain cells. When researchers removed these aging cells in mice, seizures dropped, memory improved, and some animals avoided epilepsy altogether. The treatment used drugs already known to science, raising the possibility of quicker translation to people. The results offer new hope for patients who do not respond to existing medications.
This popular painkiller may do more harm than good
Tramadol, a popular opioid often seen as a “safer” painkiller, may not live up to its reputation. A large analysis of clinical trials found that while it does reduce chronic pain, the relief is modest—so small that many patients likely wouldn’t notice much real-world benefit. At the same time, tramadol was linked to a significantly higher risk of serious side effects, especially heart-related problems like chest pain and heart failure, along with common issues such as nausea, dizziness, and sleepiness.
Health care will get more expensive for some in 2026 – and cheaper for others
People covered by Obamacare and Medicaid may see health care costs rise, but for people on Medicare, Biden-era negotiated drug prices are set to go into effect.
Two arrested in Spanish Fork over alleged drug sales from local business
A married pair of business owners who live in Payson are facing several charges after police say they discovered them selling illegal products out of their home.
Medicare opens door to covering blockbuster drugs for weight loss
Some Medicare enrollees may soon be able to access super-popular drugs for obesity under a voluntary model program, the Centers for Medicare and Medicaid Services announced Tuesday. Eligible beneficiaries will only have to pay $50 a month.
WHO updated recommendations on HIV clinical management: recommendations for a public health approach
This document provides an overview of the updated World Health Organization recommendations for HIV clinical management, which focus on optimizing antiretroviral therapy, preventing vertical transmission, and enhancing tuberculosis prevention among individuals with HIV. These updates are intended to support global initiatives aimed at ending AIDS as a public health threat by 2030. Key changes include the introduction of new antiretroviral drugs and regimens, revised postnatal prophylaxis and breastfeeding guidelines for managing infants at risk of vertical transmission, and the endorsement of shorter tuberculosis preventive treatments to improve efficacy and adherence. The recommendations are designed to simplify and advance HIV care, promote equity, and contribute to improved health outcomes and quality of life for individuals living with HIV. The updated guidance will be incorporated into the forthcoming revision of the antiretroviral therapy chapter within the Consolidated Guidelines on HIV Prevention, Testing, Treatment, Service Delivery, and Monitoring: Recommendations for a Public Health Approach.
US health agency to negotiate prices for GLP-1 weight-loss drugs
The U.S. Centers for Medicare and Medicaid Services said on Tuesday it will negotiate drug prices with manufacturers of GLP-1 medications, in an attempt to expand access to the weight-loss treatments.
Scientists find a weak spot in deadly fungus that shut down hospital intensive care units
A deadly hospital fungus that resists nearly every antifungal drug may have an unexpected weakness. Researchers discovered that Candida auris activates specific genes during infection to hunt for nutrients it needs to survive. This insight came from a new living-host model that allowed scientists to watch the fungus in action. The findings could eventually lead to new treatments or allow current drugs to be repurposed.
US strikes another vessel in eastern Pacific, killing 1
The US military conducted a strike against a “low-profile vessel” allegedly trafficking drugs in the eastern Pacific Ocean on Monday, killing one person, according to US Southern Command.
Entertainment vs. reality: How media glamorizes opioids and warps teens' perception
Opioids are often shown in movies, music, and social media as party drugs, symbols of fun, rebellion, or a carefree lifestyle. Instead of highlighting the real dangers of addiction, withdrawal or overdose, entertainment culture turns powerful and deadly substances into aesthetic props. This glamorized image shapes how teens and young adults think about opioids, making […]